Director – Study Operations
P95 Julius Clinical
Director – Study Operations
P95 Julius Clinical
Global CRO managing complex clinical trials
P95 Julius Clinical has become AKEURA, a specialist contract research organization (CRO) helping sponsors advance medicines across their full lifecycle. Our dual expertise in early- through late-phase clinical development and real-world evidence is delivered by hands-on clinicians, scientists, and epidemiologists, drawing on more than 25 years of experience.
We’re built on the belief that a team of the right people, giving everything they’ve got to the needs of the study, will outperform any other approach. Our team of more than 500 experts spanning five continents has delivered more than 1,000 studies in over 75 countries, including regions where patients are hardest to reach. AKEURA exclusively focuses on three therapeutic areas: neuroscience, infectious diseases and vaccines, and cardiometabolic diseases. Across each, we bring the experience, reach and hands-on expertise to give every promising medicine the study it deserves.
Global CRO managing complex clinical trials
Julius Clinical is a full-service contract research organization that manages complex global clinical trials for pharmaceutical, biotech, government, and academic clients from start to finish. It provides end-to-end development services—study design, project management, patient and site recruitment, data management, and biostatistics—across all trial phases. Its strength comes from its academic heritage (originating at the Julius Center, Utrecht) and a worldwide network of KOLs and sites, with focus in CNS, cardio-metabolic, infectious, renal, and rare diseases, plus growth via partnerships such as Ampersand’s investment and the Peachtree BioResearch Solutions merger. The goal is to deliver scientifically solid, efficient trials that meaningfully impact medical practice while expanding its global footprint and depth of expertise.
Explore more opportunities at P95 Julius Clinical